Nuclear expression of β‐catenin in endometrial hyperplasia as marker of premalignancy
Antonio Travaglino(University of Insubria), Fulvio Zullo(Magna Graecia University), Luigi Insabato(Federico II University Hospital), Bruno Arduino(University of Naples Federico II), Antonio Raffone(University of Campania "Luigi Vanvitelli"), Gabriele Saccone(University of Naples Federico II), Antonio Mollo(Northwestern University), Pietro D’Alessandro(University of Salerno), Massimo Mascolo(University of Naples Federico II)
Cited by 59
Related Papers
Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2004|328
Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2005|281
The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study
|The Journal of Clinical Endocrinology & Metabolism|2004|276
The management of Asherman syndrome: a review of literature
|Reproductive Biology and Endocrinology|2013|263
The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2005|254